Cite
Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients.
MLA
Kwan, Jennifer Yin Yee, et al. “Elevation in Viral Entry Genes and Innate Immunity Compromise Underlying Increased Infectivity and Severity of COVID-19 in Cancer Patients.” Scientific Reports, vol. 11, no. 1, Feb. 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1038/s41598-021-83366-y.
APA
Kwan, J. Y. Y., Lin, L.-T., Bell, R., Bruce, J. P., Richardson, C., Pugh, T. J., & Liu, F.-F. (2021). Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients. Scientific Reports, 11(1), 1–16. https://doi.org/10.1038/s41598-021-83366-y
Chicago
Kwan, Jennifer Yin Yee, Liang-Tzung Lin, Rachel Bell, Jeffrey P. Bruce, Christopher Richardson, Trevor J. Pugh, and Fei-Fei Liu. 2021. “Elevation in Viral Entry Genes and Innate Immunity Compromise Underlying Increased Infectivity and Severity of COVID-19 in Cancer Patients.” Scientific Reports 11 (1): 1–16. doi:10.1038/s41598-021-83366-y.